Personal information

No personal information available

Activities

Collapse all

Funding (1)

The Role of Biologic Predictors in Childhood Hodgkin Lymphoma

2018-04-01 to 2021-04-30 | Grant
Lymphoma Research Foundation (New York, US)
GRANT_NUMBER:

552450
Source: check_circle
ProposalCentral

Works (14)

Pediatric relapsed/refractory ALK+ anaplastic large cell lymphoma treatment and outcomes in the targeted drug era

Blood Advances
2025-01-22 | Journal article
DOI: 10.1182/bloodadvances.2024014745
Contributors: Lianna J. Marks; Victor Ritter; Jennifer Agrusa; Kala Y. Kamdar; Julie Rivers; Rebecca A Gardner; Matthew J Ehrhardt; Kaitlin J. Devine; Charles A. Phillips; Anne F Reilly et al.
Source: check_circle
Crossref

Recommendations for surveillance of pulmonary dysfunction among childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group

eClinicalMedicine
2024-03 | Journal article
DOI: 10.1016/j.eclinm.2024.102487
Contributors: Maria Otth; Rahel Kasteler; Renée L. Mulder; Jennifer Agrusa; Saro H. Armenian; Dana Barnea; Anne Bergeron; Neel S. Bhatt; Stephen J. Bourke; Louis S. Constine et al.
Source: check_circle
Crossref

Recommendations for surveillance of pulmonary dysfunction among childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group

2023-08-31 | Preprint
DOI: 10.1101/2023.08.28.23294741
Contributors: Maria Otth; Rahel Kasteler; Renée L. Mulder; Jennifer Agrusa; Saro H. Armenian; Dana Barnea; Anne Bergeron; Neel S. Bhatt; Stephen J. Bourke; Louis S. Constine et al.
Source: check_circle
Crossref

Brentuximab vedotin use in pediatric anaplastic large cell lymphoma.

Frontiers in immunology
2023-05-18 | Journal article
DOI: 10.3389/fimmu.2023.1203471
PMID: 37275877
PMC: PMC10232850
Contributors: Agrusa JE; Egress ER; Lowe EJ
Source: Self-asserted source
Jennifer Agrusa

A preventable death: Fatal stroke due to severe iron deficiency anemia

Pediatric Blood & Cancer
2023-03 | Journal article
DOI: 10.1002/pbc.30014
Contributors: Clay T. Cohen; Jennifer E. Agrusa; Shiu‐Ki Rocky Hui; Jun Teruya; Jacquelyn M. Powers
Source: check_circle
Crossref

Acute and Late Pulmonary Effects After Radiation Therapy in Childhood Cancer Survivors: A PENTEC Comprehensive Review.

International journal of radiation oncology, biology, physics
2022-05-04 | Journal article
DOI: 10.1016/j.ijrobp.2022.01.052
PMID: 35525723
Contributors: Briere TM; Agrusa JE; Martel MK; Jackson A; Olch AJ; Ronckers CM; Kremer LCM; Constine LS; Mary Frances McAleer
Source: Self-asserted source
Jennifer Agrusa

Clinical genomic profiling of novel grey zone lymphoma paired lesions with sequential central nervous system involvement in two adolescent patients.

Haematologica
2021-09-01 | Journal article
DOI: 10.3324/haematol.2021.278936
PMID: 34162180
PMC: PMC8409016
Contributors: Benkli CY; Marcogliese AN; Agrusa JE; Adesina AM; Weiner HL; Fisher KE; Choladda V Curry
Source: Self-asserted source
Jennifer Agrusa

IFN-γ signature in the plasma proteome distinguishes pediatric hemophagocytic lymphohistiocytosis from sepsis and SIRS.

Blood advances
2021-09-01 | Journal article
DOI: 10.1182/bloodadvances.2021004287
PMID: 34461635
PMC: PMC8525230
Contributors: Howard Lin; Scull BP; Goldberg BR; Abhyankar HA; Eckstein OE; Zinn DJ; Lubega J; Agrusa J; El Mallawaney N; Nitya Gulati et al.
Source: Self-asserted source
Jennifer Agrusa

Genetic errors of immunity distinguish pediatric nonmalignant lymphoproliferative disorders.

The Journal of allergy and clinical immunology
2021-07-28 | Journal article
DOI: 10.1016/j.jaci.2021.07.015
PMID: 34329649
PMC: PMC8795244
Contributors: Forbes LR; Eckstein OS; Gulati N; Peckham-Gregory EC; Ozuah NW; Joseph Lubega; El-Mallawany NK; Agrusa JE; Maria Cecilia Poli; Vogel TP et al.
Source: Self-asserted source
Jennifer Agrusa

Defining the Inflammatory Plasma Proteome in Pediatric Hodgkin Lymphoma

Cancers
2020-12-02 | Journal article
DOI: 10.3390/cancers12123603
Contributors: Jennifer E. Agrusa; Brooks P. Scull; Harshal A. Abhyankar; Howard Lin; Nmazuo W. Ozuah; Rikhia Chakraborty; Olive S. Eckstein; Nitya Gulati; Elmoataz Abdel Fattah; Nader K. El-Mallawany et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Early evidence of pulmonary dysfunction in survivors of childhood Hodgkin lymphoma

Leukemia & Lymphoma
2020-08-23 | Journal article
DOI: 10.1080/10428194.2020.1772478
Contributors: Jennifer E. Agrusa; Viral D. Kothari; Austin L. Brown; Prakash M. Masand; Gary D. Lewis; Bin S. Teh; Arnold C. Paulino; Manuel D. Silva-Carmona; Ernestina Melicoff; Carl E. Allen et al.
Source: check_circle
Crossref

Severe therapy‐related toxicities after treatment for Hodgkin lymphoma due to a pathogenic TERT variant and shortened telomeres

Pediatric Blood & Cancer
2019-08 | Journal article
DOI: 10.1002/pbc.27779
Contributors: Jennifer E. Agrusa; Alison A. Bertuch; Courtney D. DiNardo; Sharon E. Plon; Olive S. Eckstein
Source: check_circle
Crossref

Survival disparities for second primary malignancies diagnosed among childhood cancer survivors: A population-based assessment.

Cancer
2019-06-28 | Journal article
DOI: 10.1002/cncr.32356
PMID: 31251393
Source: Self-asserted source
Jennifer Agrusa

Radiation pneumonitis in pediatric Hodgkin lymphoma patients receiving radiation therapy to the chest.

Practical radiation oncology
2018-02-04 | Journal article
DOI: 10.1016/j.prro.2018.01.007
PMID: 29730281
Source: Self-asserted source
Jennifer Agrusa
How many people are using ORCID?